RxDoctor Payments Data

Brandon Rowland, PA

Physician Assistant · Dublin, GANPI 1184946279

Payments from drug & device makers

$5,809in general payments, 2019–2025

Across 305 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$1K
  • UCB, Inc.$842
  • Johnson & Johnson$658
  • AbbVie$629
  • Pfizer$467
  • Novartis$394
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$5,21190%
  • Education$59810%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,809 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$208,684
Medicare patients
728
Services billed
4,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa31$678,005
Dupixent PenDupilumab97$403,442
Humira(Cf) PenAdalimumab16$101,513
Cosentyx Sensoready (2 Pens)Secukinumab14$100,511
RinvoqUpadacitinib12$75,631
OpzeluraRuxolitinib Phosphate12$23,319
Clobetasol Propionate286$9,114
Tacrolimus46$4,753
Triamcinolone Acetonide356$4,049
Doxycycline Hyclate168$3,671
Ketoconazole206$3,549
Metronidazole47$2,407
Fluorouracil31$2,020
Fluocinolone AcetonideFluocinolone/Shower Cap27$1,764
Levocetirizine Dihydrochloride258$1,624

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$629$75,63112 claims
Incyte CorporationOpzelura$172$23,31912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Dublin

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →